Gland Pharma consolidated net profit rises 9.79% in the March 2022 quarter

19 May 2022 , 05:16 PM

Net profit of Gland Pharma rose 9.79% to Rs 285.90 crore in the quarter ended March 2022 as against Rs 260.41 crore during the previous quarter ended March 2021. Sales rose 24.25% to Rs 1103.01 crore in the quarter ended March 2022 as against Rs 887.75 crore during the previous quarter ended March 2021. For the full year,net profit rose 21.54% to Rs 1211.66 crore in the year ended March 2022 as against Rs 996.96 crore during the previous year ended March 2021. Sales rose 27.08% to Rs 4400.71 crore in the year ended March 2022 as against Rs 3462.88 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	1103.01	887.75	24	4400.71	3462.88	27
OPM %	31.58	36.91	–	34.32	37.61	–
PBDT	411.56	373.87	10	1728.85	1433.59	21
PBT	380.48	348.94	9	1618.55	1334.81	21
NP	285.90	260.41	10	1211.66	996.96	22

Powered by Capital Market – Live News